Gezt 1 Pregnancy

• Pregnancy of Gezt 1 in details
• Gezt 1 breastfeeding
• Gezt 1 reviews

Pregnancy of Gezt 1 in details

Based on the mechanism of action and on findings from animal reproduction studies, Gezt 1 may cause fetal harm if administered during pregnancy.

Information related to the use of Gezt 1 in pregnancy is limited (Lubner 2011; Wiesweg 2014).

A pregnancy registry is available for all cancers diagnosed during pregnancy at Cooper Health (877-635-4499).

Gezt 1 breastfeeding

AU and UK: Use is contraindicated. US: A decision should be made to discontinue breastfeeding or discontinue the drug, taking into account the importance of the drug to the mother. Excreted into human milk: Unknown Excreted into animal milk: Unknown

See references

References for pregnancy information

1. Cerner Multum, Inc. "Australian Product Information." O 0
2. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
3. "Product Information. Gemzar (Gezt 1)." Lilly, Eli and Company, Indianapolis, IN.

References for breastfeeding information

1. Cerner Multum, Inc. "Australian Product Information." O 0
2. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
3. "Product Information. Gemzar (Gezt 1)." Lilly, Eli and Company, Indianapolis, IN.

References

1. PubMed Health. "Gemcitabine (By injection) (Gemcitabine Novaplus): This section provide the link out information of drugs collectetd in PubMed Health. ". http://www.ncbi.nlm.nih.gov/pubmedhe... (accessed September 17, 2018).
2. Human Metabolome Database (HMDB). "Gemcitabine: The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.". http://www.hmdb.ca/metabolites/HMDB0... (accessed September 17, 2018).
3. FDA Pharm Classes. "FDA Pharmacological Classification: FDA published a final rule that amended the requirements for the content and format of approved labeling (prescribing information) for human prescription drug and biological products in January 2006.". https://www.fda.gov/ForIndustry/Data... (accessed September 17, 2018).

Reviews

Consumer reviews

There are no reviews yet. Be the first to write one!

Your name:  Email:  Spam protection:  < Type 14 here

Information checked by Dr. Sachin Kumar, MD Pharmacology